Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HOSPIRA

  • FDA Approval
  • June 12, 2024, 08:51 UTC
  • 22
  • 0 comments

FDA approve CARBOPLATIN

Comment Full text

HOSPIRA

  • FDA Approval
  • June 12, 2024, 08:51 UTC
  • 22
  • 0 comments

FDA approve CARBOPLATIN

Comment Full text

SANOFI SYNTHELABO

  • FDA Approval
  • June 11, 2024, 17:45 UTC
  • 26
  • 0 comments

FDA approve SARILUMAB

Comment Full text

IPSEN BIOPHARM LTD

  • FDA Approval
  • June 11, 2024, 13:38 UTC
  • 31
  • 0 comments

FDA approve ELAFIBRANOR

Comment Full text

SANOFI AVENTIS US

  • FDA Approval
  • June 11, 2024, 08:40 UTC
  • 27
  • 0 comments

FDA approve TERIFLUNOMIDE

Comment Full text

CHARTWELL MOLECULAR

  • FDA Approval
  • June 11, 2024, 08:40 UTC
  • 25
  • 0 comments

FDA approve CIMETIDINE HYDROCHLORIDE

Comment Full text

RENEW PHARMS

  • FDA Approval
  • June 11, 2024, 08:40 UTC
  • 26
  • 0 comments

FDA approve EPHEDRINE SULFATE

Comment Full text

SPECGX LLC

  • FDA Approval
  • June 11, 2024, 08:40 UTC
  • 25
  • 0 comments

FDA approve LEVORPHANOL TARTRATE

Comment Full text

RISING

  • FDA Approval
  • June 11, 2024, 08:40 UTC
  • 30
  • 0 comments

FDA approve FLUPHENAZINE HYDROCHLORIDE

Comment Full text

CHARTWELL MOLECULAR

  • FDA Approval
  • June 11, 2024, 08:40 UTC
  • 18
  • 0 comments

FDA approve PREDNISONE

Comment Full text
  • Previous
  • 332
  • 333
  • 334
  • 335
  • 336
  • Next

Search

News categories

  • Technical Exchange News(10033)
  • Event(412)
  • SEC News(169702)
  • FDA Approval(9405)
  • Company Report(721)
  • Business News(112980)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin